PMC5566369_01
Diffuse vitreous opacity at the time of admission.
imcrj-10-279Fig1.jpg
PMC5566369_01_imcrj-10-279Fig1.jpg
f1-imcrj-10-279
We continued administering topical levofloxacin accompanied with intravitreal vancomycin (1 mg/0.1 mL) and amikacin (0.4 mg/0.1 mL) injection every 2 days without systemic antibiotic therapy, but hypopyon remained and vitreous opacity was found by B-scan ultrasonography (Figure 1).
External appearance of the eye with severe chemosis and hyperemia (A) and vitreous opacity (B) observed intraoperatively.
imcrj-10-279Fig2.jpg
PMC5566369_01_imcrj-10-279Fig2.jpg
f2-imcrj-10-279
Diffuse vitreous haze without vitreous hemorrhage or retinal break was found during TPPV (Figure 2), and the vitreous cavity was cleared by vitrectomy and examined by indirect ophthalmoscope to ensure media clarity.
Color fundus photography without vitreous opacity after the secondary discharge.
imcrj-10-279Fig3.jpg
PMC5566369_01_imcrj-10-279Fig3.jpg
f3-imcrj-10-279
The vitreous opacity had vanished postoperatively, and the patient was discharged on October 29, 2015 (Figure 3).
Clear external eye appearance without significant lesion at the last visit.
imcrj-10-279Fig4.jpg
PMC5566369_01_imcrj-10-279Fig4.jpg
f4-imcrj-10-279
The anterior chamber cell had diminished to a score of zero, and the BCVA recovered to 20/32 at the last visit on January 20, 2017 (Figure 4).